These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35151637)

  • 21. Early Administration of Remdesivir and Intensive Care Unit Admission in Hospitalized Pregnant Individuals With Coronavirus Disease 2019 (COVID-19).
    Eid J; Abdelwahab M; Colburn N; Day S; Cackovic M; Rood KM; Costantine MM
    Obstet Gynecol; 2022 Apr; 139(4):619-621. PubMed ID: 35134032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation.
    Padilla S; Polotskaya K; Fernández M; Gonzalo-Jiménez N; de la Rica A; García JA; García-Abellán J; Mascarell P; Gutiérrez F; Masiá M
    J Antimicrob Chemother; 2022 Jul; 77(8):2257-2264. PubMed ID: 35534369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
    Ahmed A; Munoz FM; Muller WJ; Agwu A; Kimberlin DW; Galli L; Deville JG; Sue PK; Mendez-Echevarria A; Humeniuk R; Guo S; Rodriguez L; Han D; Hedskog C; Maxwell H; Palaparthy R; Kersey K; Rojo P;
    Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38332740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compassionate Use of Remdesivir in Children With Severe COVID-19.
    Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality.
    Huang CW; Yu AS; Song H; Park JS; Wu SS; Khang VK; Subject CC; Shen E
    JAMA Netw Open; 2022 Mar; 5(3):e221455. PubMed ID: 35258575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
    Barratt-Due A; Olsen IC; Nezvalova-Henriksen K; Kåsine T; Lund-Johansen F; Hoel H; Holten AR; Tveita A; Mathiessen A; Haugli M; Eiken R; Kildal AB; Berg Å; Johannessen A; Heggelund L; Dahl TB; Skåra KH; Mielnik P; Le LAK; Thoresen L; Ernst G; Hoff DAL; Skudal H; Kittang BR; Olsen RB; Tholin B; Ystrøm CM; Skei NV; Tran T; Dudman S; Andersen JT; Hannula R; Dalgard O; Finbråten AK; Tonby K; Blomberg B; Aballi S; Fladeby C; Steffensen A; Müller F; Dyrhol-Riise AM; Trøseid M; Aukrust P;
    Ann Intern Med; 2021 Sep; 174(9):1261-1269. PubMed ID: 34251903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality comparision in patients receiving either Remdesivir or Remdesivir plus Baricitinib combination in case of moderate to severe COVID-19 Pneumonia: A retrospective study.
    Das D; Mukhopadhyay P; Banerjee D
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Trials; 2020 May; 21(1):422. PubMed ID: 32448345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    Gonzalez Suarez ML; Mara KC; Rivera CG; Chesdachai S; Draper E; Razonable RR
    PLoS One; 2024; 19(6):e0303896. PubMed ID: 38875257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study.
    Garibaldi BT; Wang K; Robinson ML; Betz J; Caleb Alexander G; Andersen KM; Joseph CS; Mehta HB; Korwek K; Sands KE; Fisher AM; Bollinger RC; Xu Y
    Clin Infect Dis; 2022 Aug; 75(1):e516-e524. PubMed ID: 34910128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.
    Benfield T; Bodilsen J; Brieghel C; Harboe ZB; Helleberg M; Holm C; Israelsen SB; Jensen J; Jensen TØ; Johansen IS; Johnsen S; Lindegaard B; Lundgren J; Meyer CN; Mohey R; Pedersen LM; Nielsen H; Nielsen SL; Obel N; Omland LH; Podlekareva D; Poulsen BK; Ravn P; Sandholdt H; Starling J; Storgaard M; Søborg C; Søgaard OS; Tranborg T; Wiese L; Christensen HR
    Clin Infect Dis; 2021 Dec; 73(11):2031-2036. PubMed ID: 34111274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge.
    Chesdachai S; Rivera CG; Cole KC; Teaford HR; Gonzalez Suarez ML; Larsen JJ; Ganesh R; Tulledge-Scheitel S; Razonable RR
    Sci Rep; 2024 Mar; 14(1):5430. PubMed ID: 38443438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study.
    Marrone A; Nevola R; Sellitto A; Cozzolino D; Romano C; Cuomo G; Aprea C; Schwartzbaum MXP; Ricozzi C; Imbriani S; Rinaldi L; Gjeloshi K; Padula A; Ranieri R; Ruosi C; Meo LA; Abitabile M; Cinone F; Carusone C; Adinolfi LE
    Clin Infect Dis; 2022 Aug; 75(1):e403-e409. PubMed ID: 35084022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy.
    Russo P; Tacconelli E; Olimpieri PP; Celant S; Colatrella A; Tomassini L; Palù G
    Viruses; 2022 May; 14(6):. PubMed ID: 35746668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remdesivir for severe covid-19: a clinical practice guideline.
    Rochwerg B; Agarwal A; Zeng L; Leo YS; Appiah JA; Agoritsas T; Bartoszko J; Brignardello-Petersen R; Ergan B; Ge L; Geduld H; Gershengorn HB; Manai H; Huang M; Lamontagne F; Kanda S; Kawano-Dourado L; Kurian L; Kwizera A; Murthy S; Qadir N; Siemieniuk R; Silvestre MA; Vandvik PO; Ye Z; Zeraatkar D; Guyatt G
    BMJ; 2020 Jul; 370():m2924. PubMed ID: 32732352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.
    Chokkalingam AP; Hayden J; Goldman JD; Li H; Asubonteng J; Mozaffari E; Bush C; Wang JR; Kong A; Osinusi AO; Gottlieb RL
    JAMA Netw Open; 2022 Dec; 5(12):e2244505. PubMed ID: 36454570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia.
    Nasrallah S; Nguyen AQ; Hitchings L; Wang JQ; Hamade S; Maxwell GL; Khoury A; Gomez LM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5970-5977. PubMed ID: 33771091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids.
    Kuno T; Miyamoto Y; Iwagami M; Ishimaru M; Takahashi M; Egorova NN
    J Antimicrob Chemother; 2021 Sep; 76(10):2690-2696. PubMed ID: 34368850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort.
    Mozaffari E; Chandak A; Zhang Z; Liang S; Thrun M; Gottlieb RL; Kuritzkes DR; Sax PE; Wohl DA; Casciano R; Hodgkins P; Haubrich R
    Clin Infect Dis; 2022 Aug; 75(1):e450-e458. PubMed ID: 34596223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?
    Boglione L; Meli G; Poletti F; Rostagno R; Moglia R; Cantone M; Esposito M; Scianguetta C; Domenicale B; Di Pasquale F; Borrè S
    QJM; 2022 Jan; 114(12):865-871. PubMed ID: 34850210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.